<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>41(2)</volume><submitter>Sanchez Fabra D</submitter><journal>Enfermedades infecciosas y microbiologia clinica (English ed.)</journal><pagination>127-128</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9903148</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns.</pubmed_title><pmcid>PMC9903148</pmcid><pubmed_authors>Sanchez Fabra D</pubmed_authors><pubmed_authors>Herrero Jordan T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns.</name><description/><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-04-18T16:14:43.176Z</modification><creation>2025-04-07T03:20:03.336Z</creation></dates><accession>S-EPMC9903148</accession><cross_references><pubmed>36759050</pubmed><doi>10.1016/j.eimce.2022.04.014</doi></cross_references></HashMap>